
Kidney Stones
Latest News
Latest Videos

More News

In total, the trial plans to enroll 7 patients with PH1 through a single center in China.

“The great news is that we have now completed recruitment. We actually recruited more than 1700 patients,” says Kari A.O. Tikkinen, MD, PhD.

Any stone fragmentation was achieved in 88% of patients.

"There are actually no clear guidelines on when to refer patients with nephrolithiasis to genetic testing," says Nicolette G. Payne, MD.

"The great news is that we have now completed recruitment. We actually recruited more than 1700 patients," says Kari A.O. Tikkinen, MD, PhD.

"I think what's really important for this is that you counsel patients before they undergo testing," says Nicolette G. Payne, MD.

Per Kaplan-Meier estimates, 95.6% of patients who underwent SURE were free of health care consumption events by 12 months, compared with 83.5% of patients who underwent URS.

"We sought to describe the genetic and clinical characteristics for patients undergoing genetic testing at our institution that were referred to genetics from our multidisciplinary stone clinic," says Nicolette G. Payne, MD.

“I think the future is very bright for endourology and pushing the envelope with different minimally invasive techniques to remove stones,” says Marcelino E. Rivera, MD.

"I think the patients that benefit the most are patients that have certain types of stones that potentially are much harder to treat with some of the more minimally invasive types of procedures," says John Michael DiBianco, MD.

"The cases that I've done have been here, at least, have been some of the most, I guess, impactful and really make me proud and happy to be a urologist and to do something [for which] the patients are incredibly grateful," says John Michael DiBianco, MD.

In preclinical studies, META-001-PH demonstrated the ability to reduce urinary oxalate excretion by up to 80%.

"You definitely need to be very adaptable. You have to have a great team," says John Michael DiBianco, MD.

"Kidney stone treatment is all about access," says Joseph Song, MD.

“With the support of the pediatric department and the pediatric urologists I work very closely with, we've been very successful in identifying the right patients,” says John Michael DiBianco, MD.

Data showed that Hispanic patients were consistently underrepresented in clinical trials, while Black participants tended to be overrepresented.

"Stones that recur in children happen about 40% to 50% of the time. That's why the American Urological Association guidelines recommend doing a complete metabolic evaluation in all children," says Katherine Chan, MD, MPH.

“Our final goal is to shift from an episodic care to continuous patient follow-up, allowing us to better understand and manage the evolution of patients over the time,” says Juan Fulla, MD, MSc.

"One day, we're going to have to move away from fee for service, so we'd be wise to try to navigate those waters ahead of time, so we're not left dealing with the aftermath when someone else has implemented it for us," says Ruchika Talwar, MD.

“For us, this approach has the potential to transform the prevention and management of urolithiasis, making health care more precise and personalized,” says Juan Fulla, MD, MSc.

"Anytime we do a PCNL...we always get a CT scan. That's pretty standard," says John Michael DiBianco, MD.

"Certainly, anybody who is a recurrent stone former, or of a young age when they develop their first stone, they automatically get a 24-hour urine test," says Joseph Song, MD.

"As I like to say, 'They are little people with small stones that cause big problems,' " says Katherine Chan, MD, MPH.

"We found that as we got better and better at doing it, the majority of patients now can go home in this fashion. They can go home the day of the procedure with nothing in them," says Mantu Gupta, MD.

"It's my opinion that no patient population benefits more from a miniaturized technique than a pediatric patient," says John Michael DiBianco, MD.















